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Background
As succinctly stated by Romero et al., “Few biological 
processes as central to the survival of a species as partu-
rition are so incompletely understood” [1]. Th   is is especially 
relevant for understanding mechanisms asso  ciated with 
preterm birth and stillbirth. Unfortunately, this lack of 
knowledge about the process of giving birth has led to 
largely empirical and ineﬀ  ective interventions.
Two compelling principles emerge from the current 
under  standing of pregnancy and parturition. First, labor 
represents a natural continuum of processes that begin at 
implantation and culminate with the return of the uterus 
to its non-pregnant state [2, 3]. Parturition proceeds 
through well-deﬁ  ned phases (Figure 1):
•  Implantation of the blastocyst within the endometrium 
and characterized by embryonic trophoblast invasion 
of maternal spiral arteries, allowing establishment of 
placentation
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© 2010 BioMed Central Ltd•  Uterine quiescence, during which embryogenesis and 
fetal growth occur and the uterus increases drama-
tically in size through hypertrophy
•  Activation of the myometrium, during which cellular 
and biochemical events occur that promote uterine 
contractility
•  Stimulation, or the onset of regular uterine contrac-
tions characteristic of labor and birth
•  Involution, during which the uterus reduces in size and 
returns to its non-pregnant state—abnormalities in 
uterine involution are associated with maternal 
postpartum hemorrhage, a leading cause of maternal 
mortality globally
Th  e overwhelming majority of pregnancy is spent in 
uterine quiescence or in activation. Less than 0.5% of 
pregnancy is spent in active labor, yet most interventions 
and research have focused on treatment of preterm labor 
or other intrapartum events. As noted below, it is likely 
that research directed at understanding the mechanisms 
maintaining uterine quiescence and the mechanisms of 
activation that allow the uterus to contract will have 
signiﬁ  cant impact upon the development of rational and 
eﬃ   cacious prevention strategies.
Th   e second compelling principle is that preterm birth 
and stillbirth are complex outcomes with multifactorial 
etiologies. Preterm birth and stillbirth represent ﬁ  nal 
common outcomes from a wide variety of causes, each 
with distinct biologic pathways [4, 5]. Unfortunately, all 
preterm births or stillbirths have usually been deﬁ  ned as 
a single endpoint, regardless of etiology, for epidemio-
logical purposes. Th  is has led to uniform and largely 
unsuccessful treatments or interventions. In fact, the 
etiolo  gies of preterm births and stillbirths diﬀ  er accord-
ing to gestational age, ethnicity, and characteristics unique 
to each population. For example, intrauterine infection 
and decidual hemorrhage are important causes of extreme 
prematurity and of stillbirth [6], while uterine 
overdistension associated with multiple gestations and 
maternal or fetal stress are important causes of preterm 
birth from 32 to 36 weeks of gestation.
Regardless of initiating factors, these pathways ulti-
mately lead to activation of the fetal membranes and 
maternal decidua, resulting in common mediators such 
as prostaglandins and metalloproteinases that stimulate 
contractility and rupture of the fetal membranes. Th  e 
ﬁ   nding that heterogeneous origins result in common 
downstream biological pathways and outcomes provides 
the opportunity to develop rational treatment strategies 
that target the unique upstream initiating event and the 
common downstream eﬀ  ectors [4].
Finally, disparities exist in medically-indicated preterm 
birth secondary to maternal illness or fetal compromise. 
In high-income countries, the greatest increases in 
preterm birth rates have occurred among late preterm 
births from 34 to 37 weeks of gestation, which now 
account for 60%-70% of all preterm births [7]. Much of 
the increase in late preterm births has been attributed to 
the increased prevalence of multiple gestations associated 
with assisted reproductive technologies and with 
medically-indicated preterm birth. Medically-indicated 
preterm birth is the most rapidly increasing cause of 
preterm birth in high-income countries, responsible for 
30% of all preterm births [7]. In the United States, 
medically indicated preterm birth increased by 55% from 
1989 through 2000 [8]. However, in resource-poor low- 
and middle-income countries where fetal and maternal 
well-being assessment technology is not available, 
medically-indicated preterm birth accounts for less than 
10% of preterm births. One consequence of this disparity 
has been a reduction in stillbirths and perinatal mortality, 
but a paradoxical increase in preterm births among high-
income countries.
Figure 1. Phases of parturition as a continuum of pregnancy
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and preterm parturition, and critical gaps in the under-
standing of these processes are described in the following 
sections.
Spontaneous term parturition
Understanding events surrounding normal parturition at 
term is necessary for an informed discussion of 
pathologic mechanisms leading to preterm parturition. 
Following implantation, the process of normal 
spontaneous parturition can be divided into the phases 
described below in Figure 1(modiﬁ  ed from [3, 9]).
Pregnancy proceeds through a series of orderly phases, 
beginning with implantation of the early blastocyst and 
culminating with delivery and return of the uterus to the 
non-pregnant state. Perturbations in any of these steps 
may cause adverse pregnancy outcomes.
Implantation
Implantation is characterized by embryonic cytotropho-
blast invasion of the endometrium and maternal spiral 
arteries and is necessary to establish normal placentation. 
Th  is process is facilitated by maternal immunologic 
processes that involve uterine natural killer monocytes 
(NK cells) and a shift from a pro-inﬂ  ammatory to an anti-
inﬂ  ammatory intrauterine milieu. Perturbations in implan-
tation  have been associated with habitual abortions, 
stillbirths, and with preeclampsia, which is an important 
cause of medically-indicated preterm birth [10].
Phase 0: Quiescence
Th   roughout the majority of pregnancy the uterus remains 
relaxed and quiescent. Myometrial activity is inhibited by 
a variety of biologic compounds including progesterone, 
nitric oxide, and relaxin. Rare uterine contractions during 
the quiescent phase are of low frequency and amplitude 
and are poorly coordinated throughout the uterus; these 
are commonly referred to as Braxton-Hicks contractions 
in women. Th   e poor coordination of these contractions is 
due to an absence of gap junctions and contractile-
associated proteins that otherwise allow direct cell-to-
cell coupling of electrical signaling [11].
Phase 1: activation
Myometrial activation occurs in Phase 1 and is charac-
terized by increased expression of myometrial 
contractile-associated proteins and cellular receptors for 
oxytocin and prostaglandins, both of which stimulate 
uterine contractility [12]. Th  e signals for myometrial 
activation come from uterine stretch (which induces 
contractile-associated protein and oxytocin gene 
expression) and from maturation of the fetal hypo-
thalamic-pituitary-adrenal (HPA) axis, as characterized 
below.
Phase 2: stimulation
Phase 2 is a progressive cascade of events leading to a 
common pathway of parturition involving high ampli-
tude, regular uterine contractions, cervical ripening, and 
activation of the decidua and fetal membranes. Estrogens, 
produced by the placenta play a central role in the 
coordination of these events. Estrogens increase the 
expression of many contraction-associated proteins, 
including connexin 43, and of oxytocin and prostaglandin 
receptors; estrogens also promote prostaglandin produc-
tion and increases myosin light-chain kinase (MLCK, 
which stimulates myometrial contractions) [3]. Th  ese 
changes promote myometrial contractility. Additionally, 
there is a shift in progesterone receptor (PR) isoforms 
from the normally dominant PR-B to a truncated, 
in  active PR-A, leading to a state of functional proges-
terone withdrawal that promotes myometrial contract-
ility. Placental estrogen production is dependent upon 
precursor fetal adrenal androgens that are aromatized by 
placental steroid aromatase into estrogens. Th  us, the 
events of Phase 2 are characterized by maturation and 
activation of the fetal HPA axis. Th  e events leading to 
fetal HPA activation are incompletely understood but it is 
thought that placental corticotrophin-releasing hormone 
(CRH) plays a central role [13]. CRH, a neuropeptide of 
predominantly hypothalamic origin, is also expressed in 
the human placenta and membranes and released in 
exponentially increasing amounts over the course of 
gestation into maternal and fetal compartments. Th  e 
trajectory of CRH rise has been associated with the 
length of gestation [14]. Th  ese ﬁ  ndings have led some 
researchers to suggest that placental CRH may act as a 
“placental clock” and regulate the length of gestation [14]. 
Placental CRH synthesis is stimulated by adrenal 
glucocorticoids. Placental CRH, in turn, promotes fetal 
cortisol and androgen production, and this positive 
feedback loop is progressively ampliﬁ  ed, thereby driving 
the process forward from fetal HPA activation to 
estrogen biosynthesis and parturition.
Cervical softening and decidual and fetal membrane 
activation also occur during Phase 2. Cervical ripening is 
characterized by a decrease in total collagen content, an 
increase in collagen solubility, and an increase in 
collagenolytic activity that results in the remodeling of 
the extracellular matrix of the cervix [15]. Prostaglandins, 
estrogens, progesterones, and inﬂ  ammatory cytokines all 
promote extracellular matrix metabolism and cervical 
ripening. Decidual and fetal membrane activation refers 
to a complex set of anatomical and biochemical events 
eventually resulting in the rupture of membranes. Th  e 
precise mechanism of the decidual and fetal membrane 
activation is not yet known, but extracellular matrix-
degrading enzymes such as matrix metalloproteinase 1 
(MMP-1), interstitial collagenase, MMP-8 (neutrophil 
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and plasmin have been implicated. Th  ese enzymes 
degrade extracellular matrix proteins (e.g., collagens and 
ﬁ   bronectins), thereby weakening the membranes and 
eventually leading to the rupture of membranes.
Phase 3: involution
Phase 3 begins with the third stage of labor and involves 
placental separation and uterine contraction. Placental 
separation occurs by cleavage along the plane of the 
decidua basalis. Uterine contraction is essential to 
prevent bleeding from large venous sinuses that are 
exposed after delivery of the placenta, and is primarily 
aﬀ   ected by oxytocin. Postpartum hemorrhage, an 
abnormality of Phase 3, is a leading cause of maternal 
mortality worldwide.
Summary of spontaneous term parturition
Parturition involves a progressive cascade of events 
initiated by HPA activation and increased placental CRH 
expression, leading to a functional progesterone with-
drawal and estrogen activation, which results in the 
expression and activation of contraction-associated proteins 
(CAPs), including oxytocin, and prostaglandin receptors. 
Th  is biological cascade eventually leads to a common 
pathway involving cervical ripening, uterine contractility, 
decidual and fetal membrane activation, and, in the 
second stage, increases in maternal oxytocin. It has been 
hypothesized that both preterm and term labor share this 
common pathway and that pathological stimuli of 
parturition, as described in the following sections, may 
act in concert with the normal physiological preparation 
for labor, especially after 32 weeks of gestation. Prior to 
32 weeks of gestation, a greater degree of pathological 
stimulus may be required to initiate labor.
One fundamental diﬀ  erence between the spontaneous 
parturition at term and preterm labor is that term labor 
results from physiological activation of components of 
the common pathway, while preterm labor arises from 
pathological processes that activate one or more of the 
components of the common pathway of parturition. 
However, further research is necessary to answer 
fundamental questions, including: 1. What are the 
mecha  nisms that maintain uterine quiescence for greater 
than 95% of the total length of gestation? 2. What is the 
basis for the disparities in gestational length and risks of 
preterm birth between ethnic and socioeconomic 
groups? 3. Do they have a biologic basis, or can they be 
accounted for by environmental factors?
Pathways to spontaneous preterm birth
Preterm birth may result from preterm labor with intact 
fetal membranes, preterm rupture of the fetal mem-
branes, or from iatrogenic preterm delivery for maternal 
or fetal indications. In high-income countries, approxi-
mately 40-45% of preterm births follow preterm labor, 
25-40% follow preterm premature rupture of the fetal 
membranes, and 30-35% are indicated deliveries [7]. In 
contrast, studies from countries in Latin America have 
shown that almost 70% are spontaneous preterm births, 
16-21% involve rupture of membranes, and 11-15% have 
medically induced causes [16, 17].
Until recently, a tendency has existed among obste-
tricians and epidemiologists to combine, for statistical 
purposes, all preterm births occurring between 22 and 
37 weeks of gestation. Th   e traditional empirical approach 
to preterm labor presupposed a single pathologic process 
for which treatment could be uniform. It is now clear the 
causes of preterm labor are multifactorial and vary 
according to gestational age, genetic, and environmental 
factors. A useful paradigm for pathologic pathways 
contributing to preterm birth has been provided by 
Lockwood and Kuczynski [18]. Th  ese pathways include 
systemic and intrauterine infection, uteroplacental 
throm  bosis and intrauterine vascular lesions or decidual 
hemorrhage, stress, and uterine overdistension (Table 1). 
While each of these may cause preterm birth at any point 
in gestation, infection/inﬂ  ammation predominates as a 
cause of early preterm birth (24-32 weeks gestation), and 
stress and uterine overdistension are associated mostly 
with late preterm birth (32-37 weeks).
Additionally, each pathway may be inﬂ  uenced by gene-
environment interactions and by genetic variability in 
single nucleotide polymorphisms, described below. 
Commonly occurring pathways of preterm parturition 
are described below.
Infection/infl  ammation
Infections are strongly related to preterm birth [19]. 
Infectious sources linked to preterm birth include intra-
uterine infections, lower genital tract infections, and 
systemic maternal infections.
Intrauterine infection is recognized as one of the most 
important and potentially preventable causes of early 
preterm birth. Th  ese infections are thought to be 
responsible for up to 50% of extreme preterm births of 
less than 28 weeks of gestation, where both neonatal 
mortality and morbidity are high. Th  e prevalence of 
microbial invasion of the chorioamnion is 73% in women 
with a spontaneous preterm birth prior to 30 weeks of 
gestation, and only 16% among women with indicated 
preterm delivery without labor [20]. One sentinel study 
found the frequency of intrauterine infection with 
recovery of micro-organisms from amniotic ﬂ  uid to be 
45% at 23-26 weeks of gestation, 16% at 27-30 weeks, and 
11% at 31-34 weeks [21]. Intrauterine infection as a cause 
of preterm birth is rare beyond 34 weeks of gestation. It is 
likely that recent microbiology techniques such polymerase 
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organisms will lead to even greater estimates of infection 
as a cause of preterm birth.
Furthermore, a high proportion of women in preterm 
labor with evidence of microbial invasion of the amniotic 
ﬂ   uid are refractory to standard tocolytic therapy and 
experience rapid preterm delivery (62% versus 13% of 
women with sterile amniotic ﬂ  uid) [22]. Th   is suggests the 
pathophysiology of infection-associated preterm labor 
diﬀ  ers from that of idiopathic preterm labor. Th  ere is 
now considerable evidence to suggest the pro-inﬂ  am-
matory cytokine/prostaglandin cascade plays a central 
role in the pathogenesis of infection-associated preterm 
birth [23]. Th  ese inﬂ  ammatory mediators are produced 
by macrophages, decidual cells, and fetal membranes in 
response to bacteria or bacterial products. A role for 
selected cytokines in preterm labor is based upon the 
following observations: elevated amniotic ﬂ  uid concen-
trations of cytokines and prostaglandins are found in 
patients with intra-amniotic infection and preterm labor; 
in-vitro, bacterial products stimulate production of pro-
inﬂ  ammatory cytokines by human decidua; these cyto-
kines, in turn, stimulate production of prostaglandins by 
amnion and decidua; administration of interleukin-1 to 
pregnant mice or non-human primates induces preterm 
labor which can be prevented by administration of Il-1 
receptor antagonist protein.
Th  ere is also evidence that lower genital tract infec-
tions, especially bacterial vaginosis, or maternal systemic 
infections such as periodontitis, malaria, and syphilis 
contribute to preterm birth (see article 3 on inter  ven-
tions), as brieﬂ  y reviewed below relevant to patho  physiology.
Bacterial vaginosis and periodontitis
Observational studies show increased risks of intra-
amniotic infection, preterm delivery delivery, low birth 
weight, and endomyometritis in the presence of bacterial 
vaginosis (BV) [24, 25]. Generally, the presence of BV 
increases the risk of preterm birth by 50%. However, 
most women with BV do not have a preterm birth and 
randomized clinical trials assessing treatment of BV for 
the prevention of preterm delivery have been dis-
appointing, although treatment of women prior to 
20 weeks may be beneﬁ  cial [26]]. Th   ese are reviewed in 
article 3.
Similarly, observational studies have suggested an 
association between preterm birth or other adverse 
pregnancy outcomes and periodontal disease [27]. 
However, a recent meta-analysis of 44 studies, including 
ﬁ   ve controlled trials, found no association between 
perio  dontal disease and preterm birth although low-
income countries had higher trends towards association 
[28]. Heterogeneity between studies was noted, such as 
inconsistent disease and outcome deﬁ  nitions, inadequate 
control for confounders and insuﬃ   cient  sample  size, 
making ﬁ  rm conclusions diﬃ   cult to make [28].
Th  e associations between BV or periodontal disease 
and preterm birth, and the reasons for discrepancy in 
treatment trials are important to understand, since both 
BV and periodontal disease occur commonly in preg-
nancy. Bacterial vaginosis is seen in up to 30% of preg  nant 
women [24]. In high-income countries it is estimated that 
about 15% of adults between 21-50 years have severe 
periodontitis [29]. Th   e proportion may be even higher in 
low-income-countries. Explanations for these discrepan-
cies may include (1) gestational age at diagnosis/
enrollment; (2) past reproductive history; and (3) choice 
of treatment. Recent research indicates that both BV and 
periodontitis are complex microbiological processes, 
involving a wide variety of both cultivable and fastidious 
microorganisms not previously identiﬁ  ed that may be a 
part of the normal microﬂ  ora [30, 31]. Further, both BV 
and periodontal are associated with perturbations in the 
host inﬂ   ammatory response, characterized by a pro-
inﬂ  ammatory state. Th  ese diﬀ  erences have led some to 
hypothesize that only a subgroup of women harboring 
certain microbes associated with BV or periodontal 
disease, or with genetic diﬀ   erences in inﬂ  ammatory 
Table 1. Commonly recognized etiologies and pathways leading to spontaneous preterm birth
Pathway Examples  Mechanistic  Eff  ectors  Gestational Age When Predominant
Infection or Infl  ammation  Intrauterine   Pro-infl  ammatory cytokine/  Early preterm birth (24-32 weeks)
  Lower genital tract   prostaglandin cascade
 Systemic  Matrix  metalloproteinases
Decidual Hemorrhage  Thrombophilias,   Thrombin  Early or late preterm birth
  Placental abruption   Matrix metalloproteinases
 Autoantibody  syndromes
Maternal/Fetal HPA  Stress  Maternal/Fetal HPA activation   Late preterm birth (32-36 weeks)
Activation   Placental  CRH 
   Estrogens 
   Immune  modulation 
Pathologic Uterine  Multifetal gestation   Expression of gap junctions proteins  Late preterm birth
Overdistension Polyhydramnios  Prostaglandins 
   Oxytocin  receptors 
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women may have an abnormal inﬂ  ammatory response to 
changes in the vaginal ecosystem (either hypo- or hyper-
responsive) predisposing them to preterm delivery . In 
support of this concept, Macones, et al, recently reported 
that women with the polymorphism coding for TNFα-
308 allele that leads to up-regulation of TNF-α are at 
increased risk of preterm delivery associated with BV [32]. 
An understanding of the relationships among the human 
microbiome, host inﬂ   ammatory responsiveness and 
pregnancy outcome represents a critical research need.
Malaria
Observational studies have demonstrated an association 
between malaria and risk of preterm birth with odds 
ratios ranging between 2 and 3 [33-36], although most 
randomized trials of malaria prevention or treatment do 
not report speciﬁ  cally on preterm births. However, the 
evidence of impact on low birth weight is strong, as 
reviewed in article 3. Th   e magnitude of eﬀ  ect on preterm 
delivery appears to be based on a number of factors, 
including timing of infection [33, 37], underlying parity 
[38], severity of infection [33], increasing placental para-
sitemia [39], and local transmission rates [35]. Placental 
malaria is also signiﬁ  cantly associated with a higher risk 
for stillbirth (see article 3 on interventions).
Erythrocytes infected with P. falciparum diﬀ  er  in 
important ways from non-pregnant individuals. Placental 
sequestration occurs in the intervillous space. Placental 
infection generates an immune response that is 
characterized by monocytic inﬁ   ltrates in the placental 
intervillous space and a change in cytokine balance from 
Th   -2 to Th  -1  (speciﬁ  cally increased levels of TNF-α, INF-γ, 
and IL-1β). Elevated levels of these cytokines, particularly 
TNF-α, have been associated with low birth weight and 
preterm delivery [40].
Syphilis
Syphilis, caused by Treponema pallidum, is a risk factor 
for both stillbirth and preterm birth (see article 3 on 
interventions). It is estimated to be responsible for 
460,000 abortions or stillbirths per year with higher rates 
in low-income countries [41]. Th   e study of T. pallidum is 
hindered by the fact that it cannot be cultivated for 
sustained periods using artiﬁ   cial media. However, the 
complete genome sequence of T. pallidum has been 
published within the past 10 years and provides oppor-
tunities for new insight into its pathogenesis. Little is 
known about its mechanism of action or determinants of 
virulence [42]. Treponema are able to cross the placenta 
and cause infection in the fetus [43]. Primary and 
secondary syphilis in pregnancy will lead to fetal infec-
tion in virtually all cases, with approximately 30-50% of 
pregnancies resulting in stillbirth or death shortly after 
delivery [43]. In contrast, fetal infection is less common 
with tertiary syphilis. Th   e immune response to T. pallidum 
in pregnancy has not been vigorously studied, but the 
dampening of the intensity of the innate and cell-mediated 
immune response to favor the maintenance of the fetus 
may result in incomplete clearance and the development 
of chronic infection and adverse pregnancy outcome [43]. 
However, the nature and role of the maternal-fetal immune 
response, their interactions, and eﬀ   ect on pregnancy 
outcome remains poorly understood [44].
Decidual hemorrhage/thrombosis
Decidual hemorrhage may cause either late or early 
preterm birth. Vascular lesions of the placenta are 
commonly associated with preterm birth and preterm 
premature rupture of membranes (PPROM). Vascular 
lesions of the placenta have been reported in 34% of 
women with preterm delivery, 35% of women with 
PPROM, and in 12% of term uncomplicated deliveries 
[45]. Th  ese lesions may be characterized as failure of 
physiologic transformation of the spiral arteries, 
atherosis, and maternal or fetal arterial thrombosis. Th  e 
proposed mechanism linking vascular lesions to preterm 
birth is related to utero-placental ischemia. Although the 
pathophysiology remains unclear, thrombin is thought to 
play a central role.
Independent of its critical role in coagulation, thrombin 
is a multifunctional protease that elicits contractile activity 
of vascular, intestinal, and myometrial smooth muscle. 
Th  rombin stimulates increases in basal tone and phasic 
contractions in longitudinal myometrial smooth muscle in 
vitro, in a dose-dependent manner [46]. Recently, these in 
vitro observations have been conﬁ  rmed with an in vivo 
model utilizing thrombin and myometrial contractility 
could be signiﬁ  cantly reduced by the addition of heparin, a 
known thrombin inhibitor. Th  ese in vitro and in vivo 
experiments provide a possible mechanistic explanation 
for increased uterine activity clinically observed in 
abruption placentae and preterm birth following ﬁ  rst or 
second trimester bleeding.
A relationship between thrombin and PPROM may 
also exist. Matrix metalloproteinases (MMPs) break down 
the extracellular matrix of the fetal membranes and the 
choriodecidua and contribute to PPROM, as discussed 
below. In vitro, thrombin signiﬁ  cantly increases MMP-1, 
MMP-3, and MMP-9 protein expression in decidual cells 
and fetal membranes collected from uncomplicated term 
pregnancies [47-49]. Th   rombin also elicits a dose-
dependent increase in decidual interleukin-8, a chemo-
attractant cytokine responsible for neutrophil recruit-
ment [50]. Overt placental abruption, an extreme example 
of decidual hemorrhage, is also associated with a marked 
decidual inﬁ   ltration of neutrophils, a rich source of 
proteases and matrix metalloproteinases [50]. Th  is may 
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membranes (PROM) in the setting of decidual hemorrhage.
Maternal or fetal HPA activation: stress
Stress results in preterm activation of the maternal or 
fetal HPA axis and is increasingly recognized as an 
important cause of late preterm birth. Stress may be 
simply deﬁ   ned as any challenge, whether physical or 
psychological, that threatens or is perceived to threaten 
homeostasis of the patient. Several studies have found 
50% to 100% increases in preterm birth rates associated 
with maternal stress, usually deﬁ  ned as a composite of 
life events, anxiety, depression, or perceived stress [51]. 
Neuroendocrine, immune, and behavioral processes 
(such as depression) have been linked to stress-related 
preterm birth. However, the most important processes 
linking stress and preterm birth are neuroendocrine, 
resulting in preterm activation of the HPA axis. Th  ese 
processes are mediated by placental CRH (reviewed in 
[52]). In vitro studies of human placental cells have shown 
CRH is released from cultured human placental cells in a 
dose-response manner to all major biological eﬀ  ectors of 
stress, including cortisol, catecholamines, oxytocin, 
angiotension II, and interleukin-1. In vivo studies have 
also found signiﬁ   cant correlations between maternal 
psychosocial stress and maternal plasma levels of CRH, 
ACTH, and cortisol. Several studies have related early 
maternal plasma CRH to the timing of birth. Hobel and 
colleagues [53] conducted serial assessments of CRH 
over the course of gestation and found that compared 
with women delivering at term, women delivering 
preterm had signiﬁ  cantly elevated CRH levels as well as a 
signiﬁ  cantly accelerated rate of CRH increase over the 
course of their gestation. In addition, they found that 
maternal psychosocial stress levels at mid-gestation 
signiﬁ   cantly predicted the magnitude of increase in 
maternal CRH levels between mid-and later-gestation.
Th  ese data suggest the relationship between maternal 
psychological stress and prematurity may be mediated by 
prematurely increased expression of placental CRH. In 
term parturition, placental CRH activation is driven largely 
by the fetal HPA axis in a forward feedback loop upon fetal 
maturation. In preterm parturition the maternal HPA axis 
may drive placental CRH expression [52]. Maternal stress, 
in the absence of other mediators of preterm birth such as 
infection, results in increased levels of biological eﬀ  ectors 
of stress including cortisol and epinephrine, which could 
activate placental CRH gene expression. Placental CRH, in 
turn, can stimulate fetal secretion of cortisol and DHEA-S 
(via activation of fetal HPA axis) and placental synthesis of 
estrogens and prostaglandins, thereby precipitating 
preterm delivery (reviewed in [54]). Stress may contribute 
to the increased rates of preterm birth observed among 
African-Americans in the United States.
Asphyxia may represent a common ﬁ  nal outcome for a 
variety of pathways that include stress, hemorrhage, 
preeclampsia, and infection. Asphyxia plays an important 
role in preterm birth, stillbirth, and adverse neonatal 
developmental sequelae. Chronic asphyxia—associated 
with insuﬃ     ciency of the utero-placental circulation—
may occur in placental infection such as malaria, or 
maternal illnesses (e.g., diabetes, preeclampsia, chronic 
hypertension), and is characterized by activation of the 
fetal HPA axis and subsequent preterm delivery.
Uterine overdistension
Uterine overdistension plays a key role in the onset of 
preterm labor associated with multiple gestations, 
polyhydramnios, and macrosomia. Multiple gestations, 
frequently attributable to assisted reproduction tech-
nologies (ART) including ovulation induction and 
in-vitro fertilization, are one of the most important 
causes of late preterm birth in high-income countries 
(HICs). In the United States, for example, ART accounts 
for 1% of all live births, but 17% of all multiple births; 53% 
of neonates conceived as a result of ART in 2003 were 
multiples [4]. Th  e mechanisms whereby uterine over-
distension might lead to preterm labor are incompletely 
understood, and appropriate animal models are lacking. 
Uterine stretch induces expression contraction-asso-
ciated proteins such as oxytocin receptors and 
connexin-43 [55, 56]. In vitro stretch of myometrial strips 
also increases prostaglandin H synthase 2 (PGHS-2) and 
prostaglandin E [57]. Stretching the muscle of the lower 
uterine segment has been shown to increase interleukin-8 
(IL-8) and collagenase production, which in turn 
facilitates cervical ripening [58, 59]. However, experi-
mental animal models for uterine overdistension do not 
currently exist, and human studies have been entirely 
observational in nature. Th  is is a critical gap in our 
understanding, given the increasing prevalence of 
multiple gestations in HICs.
Cervical insuffi   ciency
Cervical insuﬃ   ciency has traditionally been associated 
with second trimester pregnancy losses, but recent 
evidence suggests that cervical disorders are associated 
with a wide variety of adverse pregnancy outcomes, 
inclu  d  ing early preterm birth [60-62]. Cervical insuﬃ   -
ciency has traditionally been identiﬁ  ed among women 
with a history of recurrent mid-trimester pregnancy 
losses in the absence of recognized uterine contractions. 
Th  ere  are  ﬁ   ve recognized or possible causes: (1) 
congenital disorders; (2) in-utero diethylstilbestrol expo-
sure (3) loss of cervical tissue following a surgical 
procedure such as Loop Electrosurgical Excision Procedure 
(LEEP) or conization; (4) traumatic damage; and (5) 
infection.
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ﬁ  ciency were oﬀ  ered cervical cerclage in early preg  nancy. 
However, it has been proposed, and it is most likely, that 
most cases of cervical insuﬃ     ciency represent a con-
tinuum of premature tissue remodeling and cervical 
shortening from other pathological processes for which 
cerclage may not always be appropriate and are better 
predicted by cervical length determined by transvaginal 
ultrasonography [60]. Cervical length measured by 
transvaginal ultrasound is inversely correlated with risk 
of preterm birth [61]; 50% of women with a cervical 
length of 15 millimeters or less at 22-24 weeks deliver 
prior to 32 weeks of gestation[63]. Further, there is a 
correlation between the length of a previous gestation 
resulting in preterm birth and cervical length in the next 
pregnancy, but no correlation with an obstetrical history 
of cervical insuﬃ   ciency and cervical length in the next 
pregnancy [60].
Th  ese data suggest that the true cervical insuﬃ   ciency 
occurs infrequently, and a short cervix more frequently 
occurs as a consequence of premature cervical remodel-
ing as a result of a pathological process. Infection and 
inﬂ   ammation likely play a signiﬁ   cant role in cervical 
shortening and premature dilation. Fifty percent of 
patients evaluated by amniocentesis for mid-trimester 
asymptomatic cervical dilation and 9% of patients with a 
cervical length of <25 millimeters but without cervical 
dilation have evidence of intra-amniotic infection[64, 65]. 
Th  ese data suggest an important role for ascending 
intrauterine infection, as outlined above, in the short 
cervix and cervical insuﬃ   ciency.
Preterm premature rupture of the fetal membranes
Regardless of the etiology or mechanistic pathway to 
spontaneous preterm labor, preterm birth is usually 
preceded by preterm premature rupture of the fetal 
membranes. Preterm premature rupture of membranes 
(PPROM) accounts for 25-40% of preterm births [7, 66] 
and represents a ﬁ  nal common pathway to preterm birth. 
Th  us, an understanding of the mechanistic pathways 
leading to PPROM is important in understanding the 
biologic basis of prematurity. Preterm pre-labor rupture 
of membranes has been associated with intrauterine 
infection, tobacco use, abruption, multiple gestations, 
previous PPROM, previous cervical surgery or laceration, 
a short cervix by ultrasound, genetic connective tissue 
disorders, and vitamin C deﬁ  ciency.
Collagen provides the major structural strength for the 
fetal membranes. Loss of collagen and structural strength 
leading to rupture of the membranes is mediated by 
matrix metalloproteinases (MMPs), a large family of 
enzymes that act to degrade collagen and remodel tissue. 
Matrix metalloproteinase types 1 and 8 are collagenases 
that act to degrade collagen types I, II, and III. Th  e 
activity of MMPs is regulated at several levels, but most 
importantly by tissue inhibitors of MMPs (TIMPs). A 
balance between activators and tissue inhibitors of 
metalloproteinases controls metalloprotease activity. An 
increased ratio of MMP 9 to TIMP 1 is associated with 
decrease tensile strength of fetal membranes (reviewed in 
[67]. MMPs 1-3, 8, 9 and 14 are upregulated in the 
amnion and chorion and their concentrations increased 
in amniotic ﬂ  uid in PPROM [67]. Amniotic ﬂ  uid MMP 9 
concentrations are increased in the amniotic ﬂ  uid  of 
patients with PPROM, and to a lesser extent in preterm 
birth [68]. Increased pro-MMP 9 is found overlying the 
cervix in term gestation.
Th  e activity of MMP’s is primarily upregulated by 
decidual/fetal membrane activation during Phase 2 of 
spontaneous parturition at term. However, in pathologic 
conditions associated with preterm birth, MMP 
production is stimulated by infection, inﬂ  ammation, or 
decidual hemorrhage. Bacteria or bacterial products 
directly secrete collagenases or stimulate MMP production 
[69]. Pro-inﬂ  ammatory cytokines such as IL-1 and TNF-
alpha also increase MMP production and decrease 
TIMPs in cultured membranes [70]. Th  rombin,  generated 
as a result of choriodecidual hemorrhage, also increases 
MMP-9 production in amniochorion cultures [49]. 
Finally, stretching of the membranes by uterine over-
distension may result in PROM by increasing inter-
leukin-8 and MMP activity [58].
Genetics, environment and gene-environment 
interactions
Th   ere is compelling evidence that a genetic predisposition 
to preterm birth exists [71, 72]. Th   e evidence for a genetic 
or epigenetic contribution to preterm birth includes: 1. 
twin studies that demonstrate heritability; 2. increased 
recurrence risks for preterm birth among women with 
prior preterm birth; 3. increased risks of having preterm 
birth for women who were themselves born preterm; 4. 
increased risks of preterm birth for sisters of women who 
have had a preterm birth; and 5. racial disparities in 
preterm birth that are independent of socioeconomic 
factors (see [71] for a review). Twin studies have indicated 
a heritability of 25-40% for preterm birth [73].
Genome-wide association studies, however, have failed 
to identify consistent candidate genes for preterm birth. 
Th   is is likely due to genetic heterogeneity. Preterm birth 
is a complex phenotype, with many etiologic and patho-
physiological pathways that likely cannot be explained by 
genetic variation alone. An alternative approach has been 
selective candidate gene studies that have focused upon 
single nucleotide polymorphisms (SNPs) within selected 
genes. It is well established that the activity of many 
genes may be modiﬁ  ed by SNPs that normally occur with 
varied frequencies across populations. It is estimated that 
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genome and constitute 90% of the variation in a 
population. Th  e most common patterns of these poly-
morphisms are currently being assessed in the Inter-
national HapMap Project [74]. More than 30 SNPs have 
been associated with increased or decreased risks of 
preterm birth or preterm premature rupture of the 
membranes [75,76]. Single nucleotide polymorphisms 
associated with preterm birth have predominately been 
in inﬂ   ammatory and tissue remodeling pathways. 
Important ethnic diﬀ   erences in SNP frequencies may 
help explain racial disparities in preterm birth [77].
Th   e role of genetic variation in stillbirth has not been 
explored.
Various environmental exposures have also been linked 
to poor pregnancy outcomes. Th  e harmful eﬀ  ects  of 
smoking during pregnancy are well established and it has 
been causally associated with preterm delivery and 
stillbirth (see article 3 on interventions).
Maternal serum and umbilical cord blood levels of 
pesticides such as dichlorodiphenyl trichloroethane 
(DDT) are associated in some, but not all, studies with 
preterm delivery [78]. Other organophosphate pesticide 
metabolites are associated with preterm birth at 
increasing exposure levels in the later part of pregnancy 
[79]. Finally, air pollution (particulate matter, carbon 
monoxide, lead, ozone, nitrogen dioxide, and sulfur 
dioxide) is associated with a variety of poor birth 
outcomes, including preterm birth [79]. Particulate 
matter is associated with small increases in preterm birth 
risk in studies from a number of countries such as China 
and the United States. Evidence is insuﬃ   cient to infer 
causality between preterm birth and other air pollutants, 
but available data justiﬁ  es further studies [80].
Investigation of interactions between genetics and 
environmental exposures are increasing, but is still 
limited. One recent example is the interaction between 
tobacco smoke exposure and preterm delivery [81, 82] 
Smoking is an important risk factor for preterm birth, 
but not all women exposed to the same level of smoke 
deliver preterm. Gene polymorphisms in cytochrome 
P-450 1A1 (CYP1A1) and glutathione S-transferase theta 
1 (GSTT1) have been demonstrated to increase the risk 
of low birth weight and preterm birth among smokers, 
but not among non-smokers [81,82]. Th   ese genes encode 
for enzymes involved in metabolism and detoxiﬁ  cation of 
polycyclic aromatic hydrocarbon, an important carcino-
gen in tobacco smoke [82]. Women who smoke are also 
at increased risk of preterm delivery if they have certain 
factor V gene variants [83]. Th  ese women are hypothe-
sized to be more prone to the procoagulant eﬀ  ects of 
tobacco smoke. Others have examined the interaction 
between air pollution and maternal genetics. Exposure to 
high levels of particulate matter during the third 
trimester in the presence of speciﬁ  c GSTT1 polymor-
phisms has been associated with a signiﬁ  cantly increased 
risk of preterm delivery [84].
Similarly, gene polymorphisms for a variety of diﬀ  erent 
inﬂ   ammatory cytokines (e.g., tumor necrosis factor-α, 
interleukins-1, -6, -10, and their receptors and antago-
nists) have been associated with increased risks of 
preterm birth [76,85] that may interact with environ-
mental or infectious exposure. As noted above, Macones 
et al. noted an increased risk of preterm birth among 
women with bacterial vaginosis who also had a TNFα-
308A allele polymorphism [32].
It is likely that many more examples of gene or 
environmental risk factors exist. Links between adverse 
pregnancy outcomes and a variety of environmental 
exposures have been discovered with a variable degree of 
strength. Th  e data available are insuﬃ   cient  for  many 
more potential exposure elements—due to limited 
exposure, limited human health eﬀ  ects, or both. Th  ere  is 
a general lack of understanding of the dynamics of 
exposure during pregnancy; at what points in pregnancy 
is the mother/fetus most vulnerable, for example. A 
greater understanding is needed of the basic biological 
mechanisms of environmental inﬂ  uences on pregnancy 
and how they may interact with factors such as maternal 
genetics. Animal models may provide insight, but are 
limited by diﬀ  erences in critical periods of fetal develop-
ment, genetics, and species-speciﬁ  c  diﬀ  erences  in 
suscep  tibility to environmental exposures. Large-scale, 
well-designed and controlled human studies are neces-
sary to establish the impact of environmental exposures 
on pregnancy outcomes.
Pathways to stillbirth
Stillbirth is a major contributor to perinatal mortality, 
with greater than 3 million stillbirths occurring annually 
worldwide (see article 1 [86]). Unfortunately, despite its 
global impact, research into etiologic mechanisms 
responsible for stillbirth has been hampered by the lack 
of standardized deﬁ  nitions and reporting [6]. At least 32 
classiﬁ  cation systems of stillbirth have been described 
[87]. Many of these have been developed for a speciﬁ  c 
purpose, and therefore diﬀ  er in classifying causes, risk 
factors, and co-morbid conditions. Finally, the rate of 
“unexplained stillbirth” diﬀ   ers among settings 
depending upon available resources and interest. Th  e 
etiology of stillbirths in low- and middle-income 
countries are frequently more diﬃ   cult to ascertain. Th  e 
cause of stillbirth is attributed by verbal autopsy and 
classiﬁ   ed as macerated (antepartum) or fresh (intra-
partum) [88] (see article 1 [86]). Th   e rate of stillbirth is 
ﬁ   ve-fold greater in low-income countries, where 
resources to evaluate stillbirths—such as trained birth 
attendants—are scarce.
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birth are also associated, in extremis, with stillbirth in 
many cases. In meticulous studies from Sweden, most 
stillbirths could be attributed to an etiology [89]. In that 
study, intrauterine infections, uteroplacental insuﬃ   ciency, 
congenital malformations, placental abruption, and 
umbilical cord complications accounted for more than 
50% of stillbirths (Figure  2). Th  ese are also important 
causes of preterm birth. Fewer than 20% of stillbirths 
could not be attributed to a speciﬁ  c etiology.
In contrast, up to one-third of stillbirths in low- and 
middle-income countries are attributed to intrapartum 
asphyxia, and over 50% are “unexplained.” Th   e etiology of 
stillbirth also varies according to gestational age [90]. 
One study from Canada found that between 24 and 27 
weeks of gestation the most common causes of stillbirth 
were infection (19%), placental abruption (14%), and fetal 
anomalies (14%). Th  ese are also important factors for 
preterm birth. Beyond 28 weeks of gestation, the most 
frequent causes of stillbirth in this study were related to 
placental abruption, fetal growth restriction, and 
maternal illnesses [91]. However, the contribution of 
these pathways to stillbirth in low- and middle-income 
countries is largely unknown. Clearly, further research in 
this very important area will depend upon a uniform 
classiﬁ   cation and reporting system and better 
ascertainment in low- and middle-income countries.
New tools for reproductive research
One important limitation in understanding preterm 
births or stillbirths is the application of traditional bio-
logical methodologies to the complex process of par-
turition. Traditional biology attempts to explain complex 
phenomena by the functional properties of individual 
components of a complex system, a method described as 
“naïve reductionism” [92]. Recent advances in high-
dimensional systems biology allow the characterization 
of complex processes through the global description of 
the components of a system and their interactions. New 
tools for systems biology research now exist:
• computational design (or computer assisted in-silico 
modeling) [93]
•  genomics (characterization of genetic potential)
•  transcriptomics (characterization of gene expression)
•  proteomics (characterization of the protein output of 
gene transcription and translation)
•  metabolomics (characterization of the metabolic 
consequences of gene expression)
Collectively, these techniques have revolutionized biologic 
research in the last decade. A PubMed search reveals that 
over 39,000 articles have been published from 1998 
through 2008 utilizing these techniques (search terms 
“functional genomics, transcriptome, proteomics, meta-
bo lomics).  Th  ese techniques, however, have been only 
infrequently applied to pregnancy, with approximately 
Figure 2. Representative causes of stillbirth in high-income countries. Source: Modifi  ed from [90]. Reprinted from Acta Obstetricia et 
Gynecologica Scandinavica, 87, Varli H, Petersson K, Bottinga R, Bremme K, Hofsjo A, Holste C, Kublickas M, Norman M, Pilo C et al, The Stockholm 
classifi  cation of stillbirth, 10, 2008, with permission from Acta Obstet Gynecol Scand.
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(search term “+ pregnancy”). Th   is disparity in utilization 
of these powerful research tools is increasing (Figure 3) 
and represents a critical gap in the understanding of 
parturition and stillbirths.
Nonetheless, gene expression studies of the pregnant 
uterus have contributed to the understanding of 
parturition [94-99] (Table 2). Th  e assessment of gene 
expres  sion is typically measured by detection of mRNA 
copies produced by each gene in what are known as 
microarray assays. Th  ese studies diﬀ  ered in design, gene 
expression platforms, and the number of genes studied. Yet 
collectively, these studies demonstrate that labor is a highly 
complex biological process, potentially involving hundreds 
of genes. Th  e number of diﬀ   erentially expressed genes 
discovered, in fact, usually depends directly upon the 
number sought (Table 2). Th  e most recent study, for 
example, using an Aﬀ  ymetrix platform to ascertain activity 
of over 12,000 genes found 110 genes that were 
up-regulated, and 29 that were down-regulated in 
association with labor [99]. Regardless of technique, micro-
array analysis has led to a new under  standing of labor as 
inherently an inﬂ  ammatory process, even in the absence of 
infection [97, 99]. Approximately 25-30% of genes—with 
up-regulated expression in labor—code for inﬂ  ammatory 
proteins including chemokines, cytokines, extracellular 
remodeling proteins, and apoptosis. Th  us, these studies 
have contributed to the preliminary under  standing of 
events governing myometrial activation prior to labor.
In addition to functional genomics, it is well established 
that the activity of many genes may be modiﬁ  ed by SNPs 
that normally occur with varied frequencies across 
populations. More than 30 SNPs have been associated 
with increased or decreased risk of preterm birth or 
preterm premature rupture of membranes [75]. Consis-
tent with microarray data, the majority of the SNPs 
associated with preterm birth are in inﬂ  ammatory, apop-
totic, and tissue remodeling genes [75,76] Th  us, the 
applica  tion of systems biology, including functional 
genomics, transcriptomics, and SNP analysis, has contri-
buted to a new paradigm: myometrial activation and the 
onset of myometrial stimulation is a highly complex 
genetically-controlled inﬂ  ammatory process.
Proteomics has also made contributions in the under-
standing of abnormal parturition. Proteomics, a mass 
spectrometry-based technology, refers to a description of 
the protein complement of a system. Only 1-1.5% of the 
human genome codes for mRNA, and thus, leads to 
protein synthesis. Th  ese proteins, in turn, mediate cell-
to-cell interactions in both health and disease. Th  e  major 
advantage of proteomics is that it most directly describes 
the functional output of a cell in both health and disease. 
Proteomics primarily aids biomarker discovery in the 
diagnosis of abnormal conditions of pregnancy that may 
contribute to prematurity. As noted by the March of 
Dimes, such diagnostic tools are urgently needed to 
facilitate timely intervention [100]. Proteomic analysis of 
amniotic ﬂ  uid and cervical-vaginal secretions has been 
utilized to discover novel biomarkers for intra-amniotic 
infection [101,102], spontaneous preterm birth [75,103], 
and preterm premature rupture of the membranes [104]. 
Proteomic analysis of maternal urine has also identiﬁ  ed 
several speciﬁ  c biomarkers for preeclampsia, an impor-
tant cause of indicated preterm birth [75]. Additionally, 
comprehensive proteomic analysis has been utilized to 
fully characterize the protein complement of amniotic 
ﬂ   uid and of cervical-vaginal ﬂ   uid. Michaels, et al., 
utilizing LS/LS-MS/MS, identiﬁ   ed 219 proteins in 
amniotic ﬂ  uid, including 96 that were unique to amniotic 
ﬂ  uid [105]. Similarly, Dasari, et al. identiﬁ  ed a total of 150 
unique proteins within cervical-vaginal ﬂ  uid in pregnant 
women. Metabolism (32%) and immune response-related 
(22%) proteins were the major functional categories of 
proteins represented in the CVF proteome. A comparison 
of the CVF, serum, and amniotic ﬂ  uid proteomes showed 
that 77 proteins are unique to CVF, while 56 and 17 CVF 
proteins also occur in serum and amniotic ﬂ  uid, 
respectively [106]. Th  e  diﬀ  erential expression of proteins 
identiﬁ  ed by these and other studies will likely provide 
the basis for diagnostic tests for many adverse pregnancy 
conditions including preterm birth.
Unfortunately, none of these news tools for systems 
biology has been applied to stillbirth. It is likely that 
application of these techniques in a systems biological 
approach will lead to signiﬁ   cant contributions in the 
understanding of preterm birth and stillbirth. Because of 
the ability to study many processes simultaneously, 
however, systems biology depends upon carefully deﬁ  ned 
clinical phenotypes to avoid errors of misclassiﬁ  cation 
and upon carefully prepared samples to avoid technical 
errors. Deﬁ   ning and correctly classifying diﬀ  ering 
phenotypes, or etiologies, of preterm birth or 
Figure 3. A compilation of systems biology publications and 
proportion relating to pregnancy, semi-logarithmic scale. Data 
source: Data abstracted from PubMed, 1997-2008. Key abstracting 
words “functional genomics, transcriptomics, proteomics… alone or 
+ pregnancy”
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biologic samples—are therefore critical needs and unmet 
gaps in systems biology and in understanding parturition.
Identifi  cation of critical gaps in discovery sciences
In addition to these general observations of gaps and 
research needs, several speciﬁ   c gaps are noted and 
outlined below. In contrast to epidemiological research 
where elegant matrixes have been proposed to prioritize 
research needs and the eﬃ   cacy of interventions [107,108], 
no such matrixes exist to assess potential beneﬁ  ts and risks 
of basic or translational science in reproductive biology. 
We therefore suggest an indepen  dent assessment tool to 
assess research gaps in basic and translational science to 
be applied prospectively in assessing basic and 
translational research needs (see Figure 4 and Additional 
File 1). Th   is grading matrix, similar to CHNRI and GRADE 
is based upon the quality of evidence and the importance 
of outcomes (see Articles 1 and 3). Quality of evidence 
criteria include study design, soundness of methodology, 
consistency among or between studies, and biological 
rationale. A greater weight is given to human observations, 
consistency across species in animal models, and an 
established biologically plausible pathway. Th  e  importance 
of outcomes is based upon the ability to translate ﬁ  ndings 
into clinically relevant trials, the strength of the eﬀ  ect, and 
the size of the population that may beneﬁ  t.  Th  e ﬁ  nal 
strength of the recommendation is therefore based upon 
the strength of the evidence of contribution to preterm 
birth or stillbirth, and the potential likelihood to yield 
signiﬁ  cant beneﬁ  ts.
Speciﬁ  c gaps in basic science knowledge exist in all 
phases of parturition. Gaps that likely contribute to 
prematurity and stillbirth in which research is likely to 
yield signiﬁ  cant beneﬁ  t at each phase of parturition are 
summarized below.
Implantation
Perturbations in implantation have been associated with 
habitual abortions, stillbirths, and with preeclampsia, 
which is an important cause of medically-indicated pre-
term birth [10]. Th   ere is a critical need for a better under-
standing of the immunologic regulation of trophoblast 
invasion, and how environmental factors including chronic 
intrauterine infection, or exposure to environ  mental 
toxicants (e.g., cigarette smoke and insecticides) or other 
xenobiotic agents that may inﬂ  uence implan  tation.
Quiescence
Progesterone is thought to be critical in maintaining 
uterine quiescence, and pharmacologic progesterone 
withdrawal is associated with increased uterine contract-
ility. However, the inﬂ  uence of pollutants, xenobiotics, 
maternal intrauterine or systemic infections, or altera-
tions in immune function upon progesterone (or other 
steroid hormone) synthesis and metabolism have not 
been well described, and would likely contribute to our 
understanding of preterm birth.
Activation and stimulation
Activation is a complex process characterized by increas-
ing placental production of corticotrophin releasing 
hormone, activation of the fetal hypothalamic-pituitary-
adrenal axis, progesterone withdrawal, and increasing 
estrogen and prostaglandin biosynthesis. Th   is is a 
complex process—microarray studies of myometrium 
have demonstrated diﬀ  erential expression of more than 
100 genes in the process of activation and stimulation 
[99]. Many factors can stimulate or usurp the normal 
mechanisms of activation, including stress, infection, 
hemorrhage, endocrine or immunologic abnormalities, 
and uterine overdistension. While the role and patho-
physiology of infection-induced preterm labor or preterm 
labor associated with hemorrhage have been well-
characterized, the pathophysiology of other initiating 
factors has not. Speciﬁ   cally, there are limited or no 
animal models for stress or distension in preterm birth, 
and this represents a critical research gap. In the setting 
of intrauterine infection, both the fetal genotype and the 
maternal genotype contribute to preterm birth. However, 
Table 2. Compilation of studies comparing diff  erential gene expression in human myometrium associated with labor
 Diff  erentially Expressed Genes Detected
                                     Diff  erentially Expressed Genes Detected
    Number of Genes
Author & Reference  Platform  Sought on Platform  Up-Regulated  Down- Regulated
Aguan et al., 2000 [94]  cDNA Blot  500  12  9
Chan et al., 2002 [95]  Suppressive subtraction hybridization  Not Stated  14  16
Esplin et al., 2005 [96]  cDNA microarray  6,912  22  30
Havelock et al., 2006 [97]  UniGEM-V  9,182  42  N.S.
Bukowski et al., 2006 [98]   Aff  ymetrix  12,626                               500 genes (70% Down-Regulated)
Bollapragada et al., 2009 [99]  Aff  ymetrix  12,626  110  29
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birth is largely unexplored in preterm birth that is not 
associated with infection. Finally, the role and 
pathophysiology of preterm birth and especially stillbirth 
in the setting of systemic maternal infection is not under-
stood. Th  is is especially relevant given that 50 million 
pregnant women suﬀ   er from malaria annually, and 
malaria represents an important cause of stillbirth and 
low birth weight in low- and middle-income countries.
Conclusion
Parturition is a continuous process beginning with 
implan  tation and ending with involution of the uterus 
following birth. Active labor constitutes <0.5% of par  turi-
tion. Preterm labor and stillbirth are common endpoints 
with multifactorial etiologies that perturb, usurp, or 
activate the normal processes of parturition. Th  e 
physiologies of both normal and abnormal partu  ri  tion 
remain poorly understood.
Th  e following list includes critical gaps and needs in 
improving our understanding of these processes that are 
so important to survival:
•  Factors regulating implantation, and the potential impact 
of infection or xenobiotics in normal and abnormal 
placentation
•  Factors regulating uterine quiescence, and the role of 
progesterone in preventing preterm birth
•  Mechanisms responsible for activation of the 
myometrium from a state of quiescence to a state of 
contractility
• Appropriate animal models to replicate pathway-
speciﬁ  c etiologies of preterm birth or stillbirth that will 
contribute to rational and eﬃ   cacious interventions
• Th   e role of environmental exposure and xenobiotics in 
activation and stimulation of contractions
• Th  e contributions of both the fetal and the maternal 
genotype in determining the clinical outcome (i.e., the 
phenotype) of preterm labor and stillbirth
• Th   e role of gene:environment interactions in preterm 
birth and stillbirth
• Th  e pathophysiology of common systemic infections 
like malaria in preterm birth and stillbirth
• Th  e application of systems biology to better under-
stand the complexity of parturition
Figure 4. Grading criteria for evaluation of discovery science needs in preterm birth and stillbirth
Score
Grading Criteria  Limited
1 point 
Fair 2 
points
Good 3 
points
Excellent 4 
points
Quality of evidence
Study Design  in-vitro  in-vivo  animal
model human
Study Quality  inadequate methods  acceptable methods 
Consistency (reproducibility)  conflicting 
results 
single 
study
multiple
studies 
multiple species or 
populations 
Biologic Plausibility  little basis  plausible rationale  established 
pathway
Importance of outcomes
Translational Feasibility  limited   fair  good  excellent 
Strength of Effect  none  little   moderate large 
Population at Risk  limited  general 
Strength of recommendation/based upon potential risk and benefit 
>25 points 
Sufficient evidence of contribution to 
stillbirth/preterm birth with research likely 
to lead to significant benefit 
>20 points 
Unknown contribution to stillbirth/preterm 
birth with research likely to lead to 
significant benefit 
>10 points 
No evidence of contribution to 
stillbirth/preterm birth with unknown 
potential for benefit 
<10 points  Any estimate of importance or effect is 
uncertain
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Page 13 of 16In all of these critical needs, it is important to recognize 
that preterm birth and stillbirth are complex syndromes 
with many etiologies and pathways. In the past, research 
has been hampered by failure to recognize this hetero-
geneity and has led to conﬂ  icting ﬁ  ndings. Th  e greatest 
immediate needs to facilitate advances in the above gaps 
in knowledge include the following: carefully deﬁ  ned 
phenotypes associated with preterm birth and stillbirth; 
standardized deﬁ  nitions; uniform criteria for assessing 
outcomes; and the collection of biological specimens.
Th  e next articles in this report address existing inter-
ventions [109], scale-up [110], advocacy [111], and ethics 
[112]. Th  e  ﬁ  nal article presents a Global Action Agenda 
developed by nearly 200 global stakeholders [113]. It 
includes speciﬁ   c objectives related to normal and 
abnormal gestational biology, genetics, and the environ-
ment. Each is set to a speciﬁ  c short-, intermediate, or 
long-term timeline.
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